Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Grether

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 6, 2013
Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screeningMatthias Nettekoven, Jürgen Fingerle, Uwe Grether, et al.
Research Square|June 12, 2026
Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood-brain barrierSlava Rom, Viviana Zuluaga-Ramirez, Sachin Gaghate, et al.
Pharmacological Reviews|May 10, 2023
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 YearsMauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
ACS Pharmacology & Translational Science|August 15, 2024
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for <i>In Vivo</i> StudiesAndrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
Molecular Pharmaceutics|October 3, 2017
From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET ImagingFabien Caillé, Fanny Cacheux, Marie-Anne Peyronneau, et al.
RSC Medicinal Chemistry|July 19, 2024
Geometric deep learning-guided Suzuki reaction conditions assessment for applications in medicinal chemistryKenneth Atz, David F Nippa, Alex T Müller, et al.
Molecular Pharmacology|July 28, 2017
A Novel Selective Inverse Agonist of the CB<sub>2</sub> Receptor as a Radiolabeled Tool Compound for Kinetic Binding StudiesAndrea Martella, Huub Sijben, Arne C Rufer, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2024
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[<sup>11</sup>C]YH132: Application in Drug Development and Neurodegenerative DiseasesYingfang He, Aro Delparente, Caitlin V M L Jie, et al.
Communications Chemistry|November 21, 2023
Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screeningDavid F Nippa, Kenneth Atz, Alex T Müller, et al.
Frontiers in Pharmacology|August 28, 2023
Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptorsMorgan Scott-Dennis, Fikri A Rafani, Yicheng Yi, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|February 6, 2013
Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screeningMatthias Nettekoven, Jürgen Fingerle, Uwe Grether, et al.
Research Square|June 12, 2026
Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood-brain barrierSlava Rom, Viviana Zuluaga-Ramirez, Sachin Gaghate, et al.
Pharmacological Reviews|May 10, 2023
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 YearsMauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
ACS Pharmacology & Translational Science|August 15, 2024
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for <i>In Vivo</i> StudiesAndrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
Molecular Pharmaceutics|October 3, 2017
From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET ImagingFabien Caillé, Fanny Cacheux, Marie-Anne Peyronneau, et al.
RSC Medicinal Chemistry|July 19, 2024
Geometric deep learning-guided Suzuki reaction conditions assessment for applications in medicinal chemistryKenneth Atz, David F Nippa, Alex T Müller, et al.
Molecular Pharmacology|July 28, 2017
A Novel Selective Inverse Agonist of the CB<sub>2</sub> Receptor as a Radiolabeled Tool Compound for Kinetic Binding StudiesAndrea Martella, Huub Sijben, Arne C Rufer, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2024
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[<sup>11</sup>C]YH132: Application in Drug Development and Neurodegenerative DiseasesYingfang He, Aro Delparente, Caitlin V M L Jie, et al.
Communications Chemistry|November 21, 2023
Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screeningDavid F Nippa, Kenneth Atz, Alex T Müller, et al.
Frontiers in Pharmacology|August 28, 2023
Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptorsMorgan Scott-Dennis, Fikri A Rafani, Yicheng Yi, et al.
Pageof 10